Release Date: 27/09/11 10:03 Summary: Scheme Meetings - Chairman's address Price Sensitive: No Download Document 1.03MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%